GPCR
Structure Therapeutics Inc.
Company overview
- Market capitalization
- $7.50B
- Employees
- 233
- Latest publication
- 2026-09-29
About Structure Therapeutics Inc.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671 and ACCG-3535, an oral small molecule amylin receptor agonist that is in phase1 clinical trial for the treatment of obesity; ANPA-0073, an oral small molecule APJ receptor agonist; and LTSE-2578, an antagonist that targets lysophosphatidic acid 1 receptor, a G-protein coupled receptors implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of idiopathic pulmonary fibrosis. In addition, it develops programs, including glucose-dependent insulinotropic polypeptide receptor (GIPR) program, which identified multiple GIPR agonist, dual GLP-1R/GIPR agonist, and GIPR antagonist hits for small molecule GIPR modulation that has the potential to provide a treatment in obesity; and GCG program, which identified multiple GCG receptor (GCGR) agonist and dual GLP-1R/GCGR agonist hits for small molecule GCGR modulation. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -118,630,000USD | -89,645,505USD | 23,989,000USD | -73,787,000USD | -70,451,000USD | -56,311,000USD | -47,061,000USD | -45,836,000USD |
| Net Income | -106,159,000USD | -76,194,517USD | 33,004,000USD | -65,712,000USD | -61,661,000USD | -46,833,000USD | -36,479,000USD | -33,977,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 1,781,326USD | 0USD |
| Cost Of Revenue | — | 1,218,622USD | — | — | 853,991USD | 686,976USD | — | 267,175USD |
| Gross Profit | — | -1,218,622USD | — | — | -853,991USD | -686,976USD | 890,663USD | -267,175USD |
| Research Development | — | 66,705,307USD | 68,689,000USD | 58,989,000USD | 54,710,000USD | 42,867,000USD | 33,487,000USD | 32,598,000USD |
| Selling General Administrative | — | 22,872,000USD | 17,571,000USD | 14,798,000USD | 15,741,000USD | 13,444,000USD | 13,574,000USD | 13,238,000USD |
| Unclassified Operating Expenses | — | -1,150,424USD | -110,249,000USD | — | — | — | — | — |
| Total Operating Expenses | — | 88,426,883USD | -23,989,000USD | 73,787,000USD | 70,451,000USD | 56,311,000USD | 47,061,000USD | 45,836,000USD |
| Net Interest Income | — | 13,601,000USD | 9,185,000USD | 8,183,000USD | 8,929,000USD | 9,576,000USD | 10,718,000USD | 11,951,000USD |
| Income Before Tax | — | -76,003,951USD | 33,174,000USD | -65,604,000USD | -61,522,000USD | -46,735,000USD | -36,343,000USD | -33,885,000USD |
| Income Tax Expense | — | 190,566USD | 170,000USD | 108,000USD | 139,000USD | 98,000USD | 136,000USD | 92,000USD |
| Tax Provision | — | 190,000USD | 170,000USD | 108,000USD | 139,000USD | 98,000USD | 136,000USD | 92,000USD |
| Net Income From Continuing Ops | — | -75,968,000USD | 33,004,000USD | -65,712,000USD | -61,661,000USD | -46,833,000USD | -36,479,000USD | -33,977,000USD |
| Ebit | — | -76,003,951USD | 33,174,000USD | -65,604,000USD | -61,522,000USD | -46,735,000USD | -36,343,000USD | -33,885,000USD |
| Ebitda | — | -74,785,329USD | 33,586,000USD | -65,313,000USD | -61,231,000USD | -46,461,000USD | -36,070,000USD | -33,620,000USD |
| Depreciation And Amortization | — | 1,218,622USD | 412,000USD | 291,000USD | 291,000USD | 274,000USD | 273,000USD | 265,000USD |
| Reconciled Depreciation | — | 576,000USD | 412,000USD | 356,000USD | 291,000USD | 274,000USD | 273,000USD | 265,000USD |
| Total Other Income Expense Net | — | 13,641,554USD | 9,185,000USD | 8,183,000USD | 8,929,000USD | 9,576,000USD | 10,718,000USD | 11,951,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 3,899,285USD | 2,598,302USD | 949,174USD | 623,258USD | 20,034USD |
| Gross Profit | -3,899,285USD | -2,598,302USD | -949,174USD | -623,258USD | -20,034USD |
| Research Development | 225,255,000USD | 108,814,000USD | 70,103,000USD | 36,193,000USD | 12,364USD |
| Selling General Administrative | 61,554,000USD | 49,414,000USD | 32,672,000USD | 16,368,000USD | 3,542USD |
| Unclassified Operating Expenses | -3,140,752USD | — | — | — | — |
| Total Operating Expenses | 283,668,248USD | 158,228,000USD | 102,775,000USD | 52,561,000USD | 15,906USD |
| Operating Income | -287,567,533USD | -158,228,000USD | -102,775,000USD | -52,561,000USD | -15,906USD |
| Net Interest Income | 35,873,000USD | 36,012,000USD | 13,391,000USD | 1,257,000USD | 168USD |
| Income Before Tax | -140,687,000USD | -122,216,000USD | -89,384,000USD | -51,304,000USD | -15,738USD |
| Income Tax Expense | 515,000USD | 310,000USD | 236,000USD | 17,000USD | 138USD |
| Tax Provision | 515,000USD | 310,000USD | 236,000USD | 17,000USD | 138USD |
| Net Income | -141,202,000USD | -122,526,000USD | -89,620,000USD | -51,321,000USD | -15,876USD |
| Net Income From Continuing Ops | -141,202,000USD | -122,526,000USD | -89,620,000USD | -51,321,000USD | -15,876USD |
| Ebit | -140,687,000USD | -122,216,000USD | -75,993,000USD | -52,561,000USD | -15,906USD |
| Ebitda | -136,787,715USD | -121,224,000USD | -75,698,000USD | -52,284,000USD | -15,906USD |
| Depreciation And Amortization | 3,899,285USD | 992,000USD | 295,000USD | 277,000USD | 20,034USD |
| Reconciled Depreciation | 1,333,000USD | 992,000USD | 295,000USD | 277,000USD | 0USD |
| Total Other Income Expense Net | 146,508,454USD | 36,012,000USD | 13,391,000USD | 1,257,000USD | 168USD |
| Selling And Marketing Expenses | — | — | 1USD | — | — |
| Interest Expense | — | — | 13,391,000USD | 1,534,000USD | 5USD |
| Minority Interest | — | — | — | 0USD | — |
| Other Operating Expenses | — | — | — | — | 15,906USD |
| Net Income Applicable To Common Shares | — | — | — | — | -16,039,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,425,415,000USD | 1,508,124,000USD | 1,583,918,000USD | 832,159,000USD | 816,443,000USD | 866,549,000USD | 903,330,000USD | 933,217,000USD |
| Cash And Equivalents | 272,638,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 1,342,700,000USD | 1,458,504,000USD | 1,446,197,000USD | 799,043,000USD | 786,496,000USD | 836,882,000USD | 883,518,000USD | 915,286,000USD |
| Short Term Investments | 1,070,020,000USD | 1,142,336,000USD | 646,574,000USD | 696,131,000USD | 639,472,000USD | 684,759,000USD | 714,008,000USD | 743,156,000USD |
| Total Current Assets | 1,372,028,000USD | 1,490,598,000USD | 1,570,303,000USD | 814,022,000USD | 799,298,000USD | 849,622,000USD | 891,211,000USD | 923,651,000USD |
| Other Current Assets | 29,370,000USD | 32,094,000USD | 124,106,000USD | 14,979,000USD | 12,802,000USD | 12,740,000USD | 7,693,000USD | 8,365,000USD |
| Other Non Current Assets | 40,995,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 71,011,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 66,113,000USD | 56,984,000USD | 63,285,000USD | 57,527,000USD | 39,033,000USD | 36,487,000USD | 36,021,000USD | 33,434,000USD |
| Other Non Current Liabilities | 1,265,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,354,404,000USD | 1,447,094,000USD | 1,516,377,000USD | 770,019,000USD | 772,081,000USD | 824,638,000USD | 864,843,000USD | 896,801,000USD |
| Total Equity Including Noncontrolling Interest | 1,354,404,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 12,392,000USD | 11,971,000USD | 12,898,000USD | 11,538,000USD | 10,943,000USD | 10,831,000USD | 7,013,000USD | 7,744,000USD |
| Accounts Payable | 11,131,000USD | 7,822,000USD | 13,864,000USD | 17,796,000USD | 8,990,000USD | 8,710,000USD | 8,024,000USD | 8,447,000USD |
| Short Term Debt | 2,595,000USD | 2,609,000USD | 2,878,000USD | 2,802,000USD | 2,664,000USD | 2,471,000USD | 1,698,000USD | 1,712,000USD |
| Common Stock | 21,000USD | 21,000USD | 21,000USD | 18,000USD | 17,000USD | 17,000USD | 17,000USD | 17,000USD |
| Retained Earnings | -652,427,000USD | -546,268,000USD | -470,300,000USD | -503,304,000USD | -437,592,000USD | -375,931,000USD | -329,098,000USD | -292,619,000USD |
| Accumulated Other Comprehensive Income | -3,445,000USD | -2,195,000USD | 1,054,000USD | 825,000USD | 362,000USD | 815,000USD | 914,000USD | 2,839,000USD |
| Total Liab | — | 61,030,000USD | 67,541,000USD | 62,140,000USD | 44,362,000USD | 41,911,000USD | 38,487,000USD | 36,416,000USD |
| Other Current Liab | — | 46,553,000USD | 46,543,000USD | 36,929,000USD | 27,379,000USD | 25,306,000USD | 26,299,000USD | 23,136,000USD |
| Capital Stock | — | 21,000USD | 21,000USD | 18,000USD | 17,000USD | 17,000USD | 17,000USD | 17,000USD |
| Cash | — | 316,168,000USD | 799,623,000USD | 102,912,000USD | 147,024,000USD | 152,123,000USD | 169,510,000USD | 172,130,000USD |
| Net Debt | — | -310,376,000USD | -793,136,000USD | -95,822,000USD | -139,348,000USD | -144,536,000USD | -165,648,000USD | -167,745,000USD |
| Short Long Term Debt Total | — | 5,792,000USD | 6,487,000USD | 7,090,000USD | 7,676,000USD | 7,587,000USD | 3,862,000USD | 4,385,000USD |
| Property Plant Equipment Gross | — | 11,971,000USD | 15,867,000USD | 11,538,000USD | 10,943,000USD | 10,831,000USD | 8,649,000USD | 9,107,000USD |
| Common Stock Shares Outstanding | — | 72,442,000shares | 59,198,666shares | 58,489,666shares | 57,919,833shares | 57,350,000shares | 57,287,000shares | 57,210,000shares |
| Non Current Assets Total | — | 17,526,000USD | 13,615,000USD | 18,137,000USD | 17,145,000USD | 16,927,000USD | 12,119,000USD | 9,566,000USD |
| Non Current Liabilities Total | — | 4,046,000USD | 4,256,000USD | 4,613,000USD | 5,329,000USD | 5,424,000USD | 2,466,000USD | 2,982,000USD |
| Non Current Liabilities Other | — | 863,000USD | 647,000USD | 325,000USD | 317,000USD | 308,000USD | 302,000USD | 309,000USD |
| Non Currrent Assets Other | — | 5,555,000USD | 717,000USD | 6,599,000USD | 6,202,000USD | 6,096,000USD | 5,106,000USD | 1,822,000USD |
| Net Working Capital | — | 1,433,614,000USD | 1,507,018,000USD | 756,495,000USD | 760,265,000USD | 813,135,000USD | 855,190,000USD | 890,217,000USD |
| Unclassified Non Current Liabilities | — | 3,183,000USD | 3,609,000USD | 4,288,000USD | 5,012,000USD | 5,116,000USD | 2,164,000USD | 2,673,000USD |
| Unclassified Equity | — | 1,995,515,000USD | 1,985,581,000USD | 1,272,462,000USD | 1,209,277,000USD | 1,199,720,000USD | 1,192,993,000USD | 1,186,547,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 1,583,918,000USD | 903,330,000USD | 482,017,000USD | 97,845,000USD | 111,155,000USD | 38,704,000USD |
| Other Current Assets | 124,106,000USD | 7,693,000USD | 6,285,000USD | 2,248,000USD | 1,943,000USD | 974,000USD |
| Total Liab | 67,541,000USD | 38,487,000USD | 29,051,000USD | 212,985,000USD | 175,890,000USD | 61,173,000USD |
| Total Stockholder Equity | 1,516,377,000USD | 864,843,000USD | 452,966,000USD | -115,140,000USD | -64,735,000USD | -22,469,000USD |
| Other Current Liab | 46,543,000USD | 26,299,000USD | 18,202,000USD | 6,567,000USD | 4,594,000USD | 1,227,000USD |
| Common Stock | 21,000USD | 17,000USD | 14,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 21,000USD | 17,000USD | 14,000USD | 1,000USD | 1USD | 1USD |
| Retained Earnings | -470,300,000USD | -329,098,000USD | -206,572,000USD | -116,952,000USD | -64,736,000USD | -22,946,000USD |
| Cash | 799,623,000USD | 169,510,000USD | 129,792,000USD | 26,091,000USD | 105,305,000USD | 16,352,000USD |
| Cash And Short Term Investments | 1,446,197,000USD | 883,518,000USD | 467,323,000USD | 90,841,000USD | 107,307,000USD | 37,445,000USD |
| Total Current Assets | 1,570,303,000USD | 891,211,000USD | 473,608,000USD | 93,089,000USD | 109,250,000USD | 38,419,000USD |
| Total Current Liabilities | 63,285,000USD | 36,021,000USD | 24,740,000USD | 13,010,000USD | 8,658,000USD | 3,039,000USD |
| Net Debt | -793,136,000USD | -165,648,000USD | -124,339,000USD | -25,831,000USD | -104,684,000USD | -16,072,000USD |
| Short Term Debt | 2,878,000USD | 1,698,000USD | 1,440,000USD | 260,000USD | 349,000USD | 147,000USD |
| Short Long Term Debt Total | 6,487,000USD | 3,862,000USD | 5,453,000USD | 260,000USD | 621,000USD | 280,000USD |
| Short Term Investments | 646,574,000USD | 714,008,000USD | 337,531,000USD | 64,750,000USD | 2,002,000USD | 21,093,000USD |
| Accounts Payable | 13,864,000USD | 8,024,000USD | 4,742,000USD | 6,009,000USD | 3,484,000USD | 1,527,000USD |
| Property Plant Equipment Net | 12,898,000USD | 7,013,000USD | 8,364,000USD | 1,293,000USD | 1,794,000USD | 277,000USD |
| Property Plant Equipment Gross | 15,867,000USD | 8,649,000USD | 9,008,000USD | 1,293,000USD | 1,866USD | 277USD |
| Accumulated Other Comprehensive Income | 1,054,000USD | 914,000USD | 521,000USD | -110,000USD | -166,957,428USD | -1,000USD |
| Common Stock Shares Outstanding | 59,198,666shares | 52,641,000shares | 36,733,000shares | 36,588,000shares | 36,588,000shares | 36,588,000shares |
| Non Current Assets Total | 13,615,000USD | 12,119,000USD | 8,409,000USD | 4,756,000USD | 1,905,000USD | 285,000USD |
| Non Current Liabilities Total | 4,256,000USD | 2,466,000USD | 4,311,000USD | 199,975,000USD | 167,232,000USD | 58,134,000USD |
| Non Current Liabilities Other | 647,000USD | 302,000USD | 298,000USD | — | — | — |
| Non Currrent Assets Other | 717,000USD | 5,106,000USD | 45,000USD | 3,463,000USD | 111,000USD | 8,000USD |
| Net Working Capital | 1,507,018,000USD | 855,190,000USD | 448,868,000USD | 80,079,000USD | 100,592USD | 35,380USD |
| Unclassified Non Current Liabilities | 3,609,000USD | 2,164,000USD | 4,013,000USD | 196,575,000USD | 167,132,000USD | 58,134,000USD |
| Unclassified Equity | 1,985,581,000USD | 1,192,993,000USD | 658,989,000USD | 1,920,000USD | 166,957,427USD | — |
| Other Assets | — | — | 1USD | 3,463,000USD | 111,000USD | 8,000USD |
| Current Deferred Revenue | — | — | 356,001USD | — | — | — |
| Deferred Long Term Liab | — | — | — | 3,400,000USD | 100,000USD | — |
| Net Tangible Assets | — | — | — | -115,140,000USD | -64,735,000USD | -22,469,000USD |
| Unclassified Non Current Assets | — | — | — | -3,463,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,127,000USD |
| Stock Based Compensation | 24,273,000USD |
| Change To Liabilities | -1,308,000USD |
| Change In Working Capital | -47,200,000USD |
| Operating Cash Flow | -104,881,000USD |
| Capital Expenditures | -1,140,000USD |
| Unclassified Investing Cash Flow | -421,307,000USD |
| Investing Cash Flow | -422,447,000USD |
| Net Common Stock Issuance | -2,574,000USD |
| Unclassified Financing Cash Flow | 2,917,000USD |
| Financing Cash Flow | 343,000USD |
| Change In Cash | -526,985,000USD |
| End Cash Flow | 272,638,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -76,194,517USD | 33,004,000USD | -65,712,000USD | -61,661,000USD | -46,833,000USD | -36,479,000USD | -33,977,000USD | -26,034,000USD |
| Depreciation | 576,000USD | 412,000USD | 356,000USD | 291,000USD | 274,000USD | 273,000USD | 265,000USD | 232,000USD |
| Stock Based Compensation | 11,639,000USD | 8,069,000USD | 7,495,000USD | 7,509,000USD | 5,918,000USD | 5,831,000USD | 6,023,000USD | 4,196,000USD |
| Other Non Cash Items | -2,568,323USD | -11,823,711USD | -2,647,000USD | -3,780,000USD | -4,785,000USD | -5,558,000USD | -5,710,000USD | -2,753,000USD |
| Change To Account Receivables | 100,298,175USD | — | — | — | — | — | — | — |
| Change In Working Capital | 81,827,263USD | -94,077,289USD | 9,512,000USD | 3,083,000USD | -6,803,000USD | -534,000USD | 13,703,000USD | -2,034,000USD |
| Total Cash From Operating Activities | 15,279,423USD | -64,416,000USD | -50,996,000USD | -54,558,000USD | -52,229,000USD | -36,467,000USD | -19,696,000USD | -26,393,000USD |
| Capital Expenditures | -1,185,523USD | -1,496,000USD | -1,572,000USD | -232,000USD | -314,000USD | -16,000USD | -685,000USD | -427,000USD |
| Free Cash Flow | 14,093,900USD | -65,912,000USD | -52,568,000USD | -54,790,000USD | -52,543,000USD | -36,483,000USD | -20,381,000USD | -26,820,000USD |
| Investments | -495,765,000USD | 62,794,000USD | -49,319,000USD | 48,942,000USD | 34,033,000USD | 33,232,000USD | -189,044,000USD | -204,515,000USD |
| Total Cashflows From Investing Activities | -498,428,772USD | 56,140,000USD | -49,319,000USD | 48,942,000USD | 34,033,000USD | 33,232,000USD | -189,044,000USD | -204,515,000USD |
| Total Cash From Financing Activities | -1,747,194USD | 704,987,000USD | 56,203,000USD | 517,000USD | 809,000USD | 615,000USD | -757,000USD | 514,703,000USD |
| Change In Cash | -483,448,599USD | 696,714,425USD | -44,112,000USD | -5,099,000USD | -17,387,000USD | -2,620,000USD | -209,497,000USD | 283,795,000USD |
| Begin Period Cash Flow | 799,626,410USD | 102,911,985USD | 147,024,000USD | 152,123,000USD | 169,510,000USD | 172,130,000USD | 381,627,000USD | 97,832,000USD |
| End Period Cash Flow | 316,177,811USD | 799,626,410USD | 102,912,000USD | 147,024,000USD | 152,123,000USD | 169,510,000USD | 172,130,000USD | 381,627,000USD |
| Other Cashflows From Financing Activities | -2,581,674USD | -3,928,735USD | -855,000USD | -2,268USD | -157,373USD | 615,000USD | -757,000USD | 130,000USD |
| Issuance Of Capital Stock | — | 608,650,000USD | 57,058,000USD | — | — | 0USD | 0USD | 514,573,000USD |
| Other Cashflows From Investing Activities | — | 5,091,000USD | 5,158,000USD | — | 34,347,000USD | 33,248,000USD | 273,000USD | -275,000USD |
| Unclassified Investing Cash Flow | — | -10,249,000USD | -3,586,000USD | — | -34,033,000USD | -33,232,000USD | — | — |
| Unclassified Financing Cash Flow | — | 100,265,735USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -141,202,000USD | -122,526,000USD | -89,620,000USD | -51,321,000USD | -38,049,000USD |
| Depreciation | 1,333,000USD | 992,000USD | 295,000USD | 277,000USD | 72,000USD |
| Stock Based Compensation | 28,991,000USD | 18,794,000USD | 8,191,000USD | 2,514,000USD | 1,487,000USD |
| Other Non Cash Items | -23,047,155USD | -16,860,000USD | -5,320,000USD | -558,000USD | 268,000USD |
| Change In Working Capital | -88,273,845USD | 2,964,000USD | 6,966,000USD | 2,968,000USD | 4,062,000USD |
| Total Cash From Operating Activities | -222,199,000USD | -116,636,000USD | -79,488,000USD | -46,120,000USD | -32,160,000USD |
| Capital Expenditures | -3,614,000USD | -1,290,000USD | -2,167,000USD | -155,000USD | -1,206,000USD |
| Free Cash Flow | -225,813,000USD | -117,926,000USD | -81,655,000USD | -46,275,000USD | -33,366,000USD |
| Investments | 93,410,000USD | -358,909,000USD | -268,342,000USD | -62,108,000USD | 17,859USD |
| Total Cashflows From Investing Activities | 89,796,000USD | -358,909,000USD | -268,342,000USD | -62,108,000USD | 17,859,000USD |
| Total Cash From Financing Activities | 762,516,000USD | 515,263,000USD | 451,531,000USD | 29,014,000USD | 103,254,000USD |
| Issuance Of Capital Stock | 665,708,000USD | 514,573,000USD | 472,296,000USD | 31,500,000USD | 103,358USD |
| Change In Cash | 630,116,877USD | 39,718,000USD | 103,701,000USD | -79,214,000USD | 88,953,000USD |
| Begin Period Cash Flow | 169,510,000USD | 129,792,000USD | 26,091,000USD | 105,305,000USD | 16,352,000USD |
| End Period Cash Flow | 799,626,410USD | 169,510,000USD | 129,792,000USD | 26,091,000USD | 105,305,000USD |
| Other Cashflows From Investing Activities | 10,249,000USD | -357,619,000USD | -231,377USD | -61,953USD | 19,065USD |
| Other Cashflows From Financing Activities | -4,661,630USD | 690,000USD | -20,765,000USD | 29,014,000USD | 103,254,000USD |
| Unclassified Investing Cash Flow | -10,249,000USD | 358,909,000USD | — | — | 19,028,076USD |
| Unclassified Financing Cash Flow | 101,469,630USD | — | — | — | — |
| Change To Liabilities | — | — | — | 2,153,000USD | 1,897,000USD |
| Sale Purchase Of Stock | — | — | — | -6,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.